These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 60793)

  • 1. A new two-stage functional assay for antithrombin-III (heparin cofactor): clinical and laboratory evaluation.
    Bick RL; Kovacs I; Fekete LF
    Thromb Res; 1976 Jun; 8(6):745-56. PubMed ID: 60793
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin cofactor activity measured with an amidolytic method.
    Odegard OR; Lie M; Abildgaard U
    Thromb Res; 1975 Apr; 6(4):287-94. PubMed ID: 49087
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic measurement of antithrombin III-heparin cofactor and alpha2 macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy.
    Damus PS; Wallace GA
    Thromb Res; 1975 Jan; 6(1):27-38. PubMed ID: 46627
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: DIC-fibrinolysis with low antithrombin-heparin cofactor.
    Eurenius K; Braunstein K; Rossi TD
    N Engl J Med; 1975 Apr; 292(15):810. PubMed ID: 46588
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL; Bick MD; Fekete LF
    Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia.
    Asakura H; Saito M; Ito K; Jokaji Y; Uotani C; Kumabashiri I; Matsuda T
    Thromb Res; 1988 Jun; 50(6):895-9. PubMed ID: 3166241
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
    Cancer; 1982 Nov; 50(10):2106-10. PubMed ID: 6957257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III. Comparison of functional and immunologic assays.
    Petersen C; Kelly R; Minard B; Cawley LP
    Am J Clin Pathol; 1978 May; 69(5):500-4. PubMed ID: 77634
    [No Abstract]   [Full Text] [Related]  

  • 10. Advanced neuroblastoma and disseminated intravascular coagulation: report of six cases.
    Hatae Y; Takeda T; Hattori T; Nakadate H; Nishi M
    Jpn J Clin Oncol; 1985 Sep; 15(3):483-8. PubMed ID: 4057631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T; Jespersen J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pro and con: Consumption coagulopathy--heparin treatment? Arguments in favor of heparin treatment].
    Lasch HG; Müller-Berghaus G
    Internist (Berl); 1980 Jul; 21(7):382-4. PubMed ID: 7007274
    [No Abstract]   [Full Text] [Related]  

  • 13. [Assay for activity of heparin-antithrombin III complex during treatment of DIC with heparin and its clinical significance].
    Tomihara T; Shimazu C; Yasuda K; Kazama M; Abe T
    Rinsho Byori; 1986 Feb; 34(2):179-84. PubMed ID: 3702087
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimation of coagulation-fibrinolytic factors in DIC.
    Hasegawa H
    Bibl Haematol; 1983; (49):173-80. PubMed ID: 6667245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
    Madoiwa S
    Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
    [No Abstract]   [Full Text] [Related]  

  • 16. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
    Kobayashi T; Terao T
    Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin monomer complexes (SFMC) after substitution of antithrombin III (AT III) in consumption coagulopathy.
    Töpfer G; Ehrhardt W; Dornheim G; Seifert A; Schmidt LH; Senger C; Funke U; Schulze M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):581-5. PubMed ID: 2465977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decreased endothelial antithrombogenic activity in disseminated intravascular coagulation].
    Tsukasato T; Maruyama Y; Maruyama I
    Rinsho Ketsueki; 1987 Dec; 28(12):2110-6. PubMed ID: 2968472
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimal heparin cofactor activity in disseminated intravascular coagulation and cirrhosis.
    Braunstein KM; Eurenius K
    Am J Clin Pathol; 1976 Sep; 66(3):488-94. PubMed ID: 60879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.